These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 9652995

  • 1. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.
    Grinspoon S, Corcoran C, Askari H, Schoenfeld D, Wolf L, Burrows B, Walsh M, Hayden D, Parlman K, Anderson E, Basgoz N, Klibanski A.
    Ann Intern Med; 1998 Jul 01; 129(1):18-26. PubMed ID: 9652995
    [Abstract] [Full Text] [Related]

  • 2. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L, Walsh M, Guccione A, Cannan J, Heller H, Basgoz N, Klibanski A.
    J Clin Endocrinol Metab; 1996 Nov 01; 81(11):4051-8. PubMed ID: 8923860
    [Abstract] [Full Text] [Related]

  • 3. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.
    Miller K, Corcoran C, Armstrong C, Caramelli K, Anderson E, Cotton D, Basgoz N, Hirschhorn L, Tuomala R, Schoenfeld D, Daugherty C, Mazer N, Grinspoon S.
    J Clin Endocrinol Metab; 1998 Aug 01; 83(8):2717-25. PubMed ID: 9709937
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.
    Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB.
    Ann Intern Med; 1996 Dec 01; 125(11):873-82. PubMed ID: 8967667
    [Abstract] [Full Text] [Related]

  • 5. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.
    Strawford A, Barbieri T, Van Loan M, Parks E, Catlin D, Barton N, Neese R, Christiansen M, King J, Hellerstein MK.
    JAMA; 1999 Apr 14; 281(14):1282-90. PubMed ID: 10208143
    [Abstract] [Full Text] [Related]

  • 6. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial.
    Grinspoon S, Corcoran C, Parlman K, Costello M, Rosenthal D, Anderson E, Stanley T, Schoenfeld D, Burrows B, Hayden D, Basgoz N, Klibanski A.
    Ann Intern Med; 2000 Sep 05; 133(5):348-55. PubMed ID: 10979879
    [Abstract] [Full Text] [Related]

  • 7. Sustained anabolic effects of long-term androgen administration in men with AIDS wasting.
    Grinspoon S, Corcoran C, Anderson E, Hubbard J, Stanley T, Basgoz N, Klibanski A.
    Clin Infect Dis; 1999 Mar 05; 28(3):634-6. PubMed ID: 10194091
    [Abstract] [Full Text] [Related]

  • 8. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
    Mulligan K, Zackin R, Von Roenn JH, Chesney MA, Egorin MJ, Sattler FR, Benson CA, Liu T, Umbleja T, Shriver S, Auchus RJ, Schambelan M, ACTG 313 Study Team.
    J Clin Endocrinol Metab; 2007 Feb 05; 92(2):563-70. PubMed ID: 17090640
    [Abstract] [Full Text] [Related]

  • 9. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.
    Bhasin S, Storer TW, Asbel-Sethi N, Kilbourne A, Hays R, Sinha-Hikim I, Shen R, Arver S, Beall G.
    J Clin Endocrinol Metab; 1998 Sep 05; 83(9):3155-62. PubMed ID: 9745419
    [Abstract] [Full Text] [Related]

  • 10. Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial.
    Waters D, Danska J, Hardy K, Koster F, Qualls C, Nickell D, Nightingale S, Gesundheit N, Watson D, Schade D.
    Ann Intern Med; 1996 Dec 01; 125(11):865-72. PubMed ID: 8967666
    [Abstract] [Full Text] [Related]

  • 11. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting.
    Grinspoon S, Corcoran C, Miller K, Biller BM, Askari H, Wang E, Hubbard J, Anderson EJ, Basgoz N, Heller HM, Klibanski A.
    J Clin Endocrinol Metab; 1997 May 01; 82(5):1332-7. PubMed ID: 9141512
    [Abstract] [Full Text] [Related]

  • 12. Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting.
    Hengge UR, Stocks K, Wiehler H, Faulkner S, Esser S, Lorenz C, Jentzen W, Hengge D, Goos M, Dudley RE, Ringham G.
    AIDS; 2003 Mar 28; 17(5):699-710. PubMed ID: 12646793
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic effects of nandrolone and testosterone in adult male HIV patients with AIDS wasting syndrome (AWS): a randomized, double-blind, placebo-controlled trial.
    Sardar P, Jha A, Roy D, Majumdar U, Guha P, Roy S, Banerjee R, Banerjee AK, Bandyopadhyay D.
    HIV Clin Trials; 2010 Mar 28; 11(4):220-9. PubMed ID: 20974577
    [Abstract] [Full Text] [Related]

  • 14. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
    Grinspoon S, Corcoran C, Stanley T, Katznelson L, Klibanski A.
    J Clin Endocrinol Metab; 1998 Dec 28; 83(12):4251-6. PubMed ID: 9851759
    [Abstract] [Full Text] [Related]

  • 15. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.
    Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon SK.
    J Clin Endocrinol Metab; 2001 May 28; 86(5):2020-6. PubMed ID: 11344201
    [Abstract] [Full Text] [Related]

  • 16. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C, Corcoran C, Stanley T, Piecuch S, Klibanski A, Grinspoon S.
    J Clin Endocrinol Metab; 2000 Jan 28; 85(1):35-41. PubMed ID: 10634360
    [Abstract] [Full Text] [Related]

  • 17. Oxymetholone for the treatment of HIV-wasting: a double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women.
    Hengge UR, Stocks K, Faulkner S, Wiehler H, Lorenz C, Jentzen W, Hengge D, Ringham G.
    HIV Clin Trials; 2003 Jan 28; 4(3):150-63. PubMed ID: 12815555
    [Abstract] [Full Text] [Related]

  • 18. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
    Bhasin S, Parker RA, Sattler F, Haubrich R, Alston B, Umbleja T, Shikuma CM, AIDS Clinical Trials Group Protocol A5079 Study Team.
    J Clin Endocrinol Metab; 2007 Mar 28; 92(3):1049-57. PubMed ID: 17164307
    [Abstract] [Full Text] [Related]

  • 19. The use of testosterone in the AIDS wasting syndrome.
    Corcoran C, Grinspoon S.
    AIDS Clin Care; 1999 Apr 28; 11(4):25-6, 33-4. PubMed ID: 11366208
    [Abstract] [Full Text] [Related]

  • 20. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.
    Strawford A, Barbieri T, Neese R, Van Loan M, Christiansen M, Hoh R, Sathyan G, Skowronski R, King J, Hellerstein M.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb 01; 20(2):137-46. PubMed ID: 10048900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.